MPS treatment significantly increased the mRNA and protein expression of claudin-1 (CLDN1) and zonula occludens-1, and significantly increased transepithelial electrical resistance (TEER), which indicates Tight Junction integrity. This evidence concerns the gene CLDN1 and mucopolysaccharidosis.